FindTrial
Sign In

A clinical study to understand the effect of triturated Shigru mula (Moringa oleifera Lam. Root) as analgesic and anti inflammatory in Rheumatoid Arthritis.

Pharmacognostical and Randomized Controlled Clinical study of Bhavita sigru Mula (Moringa oleifera Lam.) as Vedanasthapana and Shothahara in Amavata - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072360
Enrollment
60
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

SV Ayurvedic College and Hospital SVIMS Campus,Tirupati, Andhra Pradesh (517501)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of Age group 18 years to 60 years Patients presenting signs and symptoms of Amavata (Rheumatoid Arthritis) Patients complaining of A?gamarda - Pain all over the body (Joints) with Gauravam (Heaviness) & Jvara (Fever) & Ap ?ka (Indigestion) & Sun ?ngat ? (Swelling of joints) with Stiffness

Exclusion criteria

Exclusion criteria: Patients below the age of 18 years to above the age of 60 years Patients with Osteoarthritis and Psoriatic Arthritis Patients with Syphilitic Arthritis, Systemic Lupus Erythematosus and Tuberculosis Patients with Post Viral reactive Osteoarthritis

Design outcomes

Primary

MeasureTime frame
Patient will get relief of joints pain, swelling of joints, tenderness and stiffness.Timepoint: At baseline, 4 weeks, 8 weeks and 12 weeks.—

Secondary

MeasureTime frame
Patient will get relief of Pain all over the body joints, Heaviness due to ama dosha, Fever, Indigestion & Swelling of joints.Timepoint: At baseline, 4 weeks, 8 weeks & 12 weeks.—

Countries

India

Contacts

Public ContactBhanu Pratap Singh

Dr. YSR University of Health Sciences, Vijayawada

drrenudixit@gmail.com9000005421

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026